• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活动性肺结核治疗过程中血清细胞因子水平的变化

Changes in serum cytokine levels in active tuberculosis with treatment.

作者信息

Deveci Figen, Akbulut H Handan, Turgut Teyfik, Muz M Hamdi

机构信息

Department of Chest Diseases, Firat Medical Center, Faculty of Medicine, Firat University, Elazig, Turkey.

出版信息

Mediators Inflamm. 2005 Oct 24;2005(5):256-62. doi: 10.1155/MI.2005.256.

DOI:10.1155/MI.2005.256
PMID:16258192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1533887/
Abstract

It has been reported that IFN-gamma, TNF-alpha, and IL-12 stimulate, and that IL-10, TGF-beta, and IL-4 suppress the protective immune response against tuberculosis. We aim to evaluate changes in the serum levels of pro and antiinflammatory cytokines in active pulmonary tuberculosis (APTB) and the possible effects of treatment on these changes. Serum IL-12p40, IL-4, IL-10, TNF-alpha, IFN-gamma, and TGF-beta1 levels were determined in 20 APTB cases (group 1) before and 2, 4, and 6 months after therapy. The same parameters were also determined in 9 inactive pulmonary tuberculosis (IPTB) cases (group 2) and 9 healthy controls (HC, group 3). Before treatment, the mean serum IFN-gamma, TNF-alpha, and IL-10 levels in group 1 were statistically higher than those in group 2 (P=.001, P=.024, P=.016, resp) or group 3 (P=.003, P=.002, P=.011, resp). The levels in group 1 decreased significantly after treatment (P=.001 for IFN-gamma, P=.004 for TNF-alpha, P=.000 for IL-10). The serum levels of IL-12p40 were significantly higher in group 1 than in group 3 (P=.012) and decreased insignificantly after treatment. There was no difference in serum IL-4 and TGF-beta1 levels among the groups (P>.05). Because the serum IL-12p40, IL-10, TNF-alpha, and IFN-gamma levels were high in APTB, we believe that these cytokines have important roles in the immune response to Mycobacterium tuberculosis (M tuberculosis). These parameters could be used in follow-up as indicators of the success of APTB therapy.

摘要

据报道,γ干扰素、肿瘤坏死因子-α和白细胞介素-12具有刺激作用,而白细胞介素-10、转化生长因子-β和白细胞介素-4则抑制针对结核病的保护性免疫反应。我们旨在评估活动性肺结核(APTB)患者血清中促炎和抗炎细胞因子水平的变化以及治疗对这些变化可能产生的影响。测定了20例APTB患者(第1组)治疗前以及治疗后2、4和6个月时血清白细胞介素-12p40、白细胞介素-4、白细胞介素-10、肿瘤坏死因子-α、γ干扰素和转化生长因子-β1的水平。还测定了9例非活动性肺结核(IPTB)患者(第2组)和9名健康对照者(HC,第3组)的相同参数。治疗前,第1组血清γ干扰素、肿瘤坏死因子-α和白细胞介素-10的平均水平在统计学上高于第2组(分别为P = 0.001、P = 0.024、P = 0.016)或第3组(分别为P = 0.003、P = 0.002、P = 0.011)。第1组治疗后这些水平显著下降(γ干扰素P = 0.001,肿瘤坏死因子-αP = 0.004,白细胞介素-10P = 0.000)。第1组血清白细胞介素-12p40水平显著高于第3组(P = 0.012),治疗后略有下降。各组血清白细胞介素-4和转化生长因子-β1水平无差异(P>0.05)。由于APTB患者血清白细胞介素-12p40、白细胞介素-10、肿瘤坏死因子-α和γ干扰素水平较高,我们认为这些细胞因子在针对结核分枝杆菌(M tuberculosis)的免疫反应中起重要作用。这些参数可作为APTB治疗成功与否的指标用于随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3480/1533887/ba36f59df7b6/MI2005-256.001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3480/1533887/ba36f59df7b6/MI2005-256.001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3480/1533887/ba36f59df7b6/MI2005-256.001a.jpg

相似文献

1
Changes in serum cytokine levels in active tuberculosis with treatment.活动性肺结核治疗过程中血清细胞因子水平的变化
Mediators Inflamm. 2005 Oct 24;2005(5):256-62. doi: 10.1155/MI.2005.256.
2
Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy.抗结核药物治疗后活动性肺结核患者血清炎症细胞因子的变化
Mol Immunol. 2014 Nov;62(1):159-68. doi: 10.1016/j.molimm.2014.06.002. Epub 2014 Jul 12.
3
Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.涂片阴性肺结核患者支气管肺泡灌洗液中细胞因子水平(肿瘤坏死因子-α、白细胞介素-2和干扰素-γ)的诊断准确性
Respiration. 2008;75(1):73-8. doi: 10.1159/000110744. Epub 2007 Nov 1.
4
[Clinical significance of detecting partial cytokines in serum of patients with pulmonary tuberculosis by cytometric bead array].[应用流式细胞仪微球阵列技术检测肺结核患者血清部分细胞因子的临床意义]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Mar;28(3):297-300.
5
[Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].[肺结核患者血清中促炎细胞因子及其受体的变化]
Zhonghua Jie He He Hu Xi Za Zhi. 2002 Jun;25(6):325-9.
6
[The cytokine profile in granulomatous lung diseases].[肉芽肿性肺病中的细胞因子谱]
Probl Tuberk Bolezn Legk. 2006(6):10-4.
7
Differential serum cytokine levels are associated with cytokine gene polymorphisms in north Indians with active pulmonary tuberculosis.差异血清细胞因子水平与印度北部活动性肺结核患者细胞因子基因多态性相关。
Infect Genet Evol. 2011 Jul;11(5):1015-22. doi: 10.1016/j.meegid.2011.03.017. Epub 2011 Apr 1.
8
In vitro levels of cytokines in response to purified protein derivative (PPD) antigen in a population with high prevalence of pulmonary tuberculosis.高肺结核患病率人群中,对纯化蛋白衍生物(PPD)抗原的细胞因子体外水平。
Hum Immunol. 2010 Nov;71(11):1099-104. doi: 10.1016/j.humimm.2010.07.006. Epub 2010 Aug 2.
9
Cytokine profile in human immunodeficiency virus positive patients with and without tuberculosis.患有和未患结核病的人类免疫缺陷病毒阳性患者的细胞因子谱
J Assoc Physicians India. 2001 Aug;49:799-802.
10
Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.结核患者经化疗后,其针对结核分枝杆菌抗原的 IgG1、IFN-γ、TNF-α 和 IL-6 反应增加。
Int Immunol. 2010 Sep;22(9):775-82. doi: 10.1093/intimm/dxq429. Epub 2010 Jul 11.

引用本文的文献

1
Evaluating the expression level of serum Interleukin-2, lipoarabinomannan and circulating MicroRNA-29a as diagnostic biomarkers for pulmonary and extra-pulmonary tuberculosis: a pilot study.评估血清白细胞介素-2、脂阿拉伯甘露聚糖和循环微小RNA-29a的表达水平作为肺和肺外结核病诊断生物标志物的初步研究。
Ann Med. 2025 Dec;57(1):2527949. doi: 10.1080/07853890.2025.2527949. Epub 2025 Jul 7.
2
Performance of eight serum cytokine/chemokine biomarkers in discriminating between active and latent tuberculosis infection in Ghana.八种血清细胞因子/趋化因子生物标志物在加纳区分活动性和潜伏性结核感染中的表现
Front Immunol. 2025 Jun 6;16:1600712. doi: 10.3389/fimmu.2025.1600712. eCollection 2025.
3

本文引用的文献

1
TNF-alpha, TGF-beta and NO relationship in sera from tuberculosis (TB) patients of different severity.不同严重程度肺结核(TB)患者血清中肿瘤坏死因子-α(TNF-α)、转化生长因子-β(TGF-β)与一氧化氮(NO)的关系
Immunol Lett. 2005 Apr 15;98(1):45-8. doi: 10.1016/j.imlet.2004.09.008.
2
Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis.活动性肺结核患者六种细胞因子的治疗后变化:纤维化稳定或加重患者之间的差异
Int J Tuberc Lung Dis. 2005 Jan;9(1):98-104.
3
Immunology of tuberculosis.
Role of Tumor Necrosis Factor in Tuberculosis.
肿瘤坏死因子在结核病中的作用。
Biomolecules. 2025 May 12;15(5):709. doi: 10.3390/biom15050709.
4
Frequency of Positive Antinuclear Antibody in People With Active Tuberculosis and Its Changes With Antitubercular Therapy.活动性结核病患者抗核抗体阳性的频率及其在抗结核治疗中的变化
Cureus. 2025 Mar 24;17(3):e81116. doi: 10.7759/cureus.81116. eCollection 2025 Mar.
5
Exploring cytokine dynamics in tuberculosis: A comparative analysis of patients and controls with insights from three-week antituberculosis intervention.探讨结核病中的细胞因子动态:来自为期三周抗结核干预的患者和对照的比较分析。
PLoS One. 2024 Aug 29;19(8):e0305158. doi: 10.1371/journal.pone.0305158. eCollection 2024.
6
and host interactions in the manifestation of tuberculosis.以及宿主在结核病表现中的相互作用。
J Clin Tuberc Other Mycobact Dis. 2024 Jun 14;36:100458. doi: 10.1016/j.jctube.2024.100458. eCollection 2024 Aug.
7
Decreased IL-1 β Secretion as a Potential Predictor of Tuberculosis Recurrence in Individuals Diagnosed with HIV.白细胞介素-1β分泌减少作为诊断为HIV的个体结核病复发的潜在预测指标。
Biomedicines. 2024 Apr 25;12(5):954. doi: 10.3390/biomedicines12050954.
8
Tuberculosis and osteoporotic fracture risk: development of individualized fracture risk estimation prediction model using a nationwide cohort study.结核病与骨质疏松性骨折风险:基于全国性队列研究开发个体化骨折风险评估预测模型。
Front Public Health. 2024 Apr 24;12:1358010. doi: 10.3389/fpubh.2024.1358010. eCollection 2024.
9
Identification of immune biomarkers in recent active pulmonary tuberculosis.近期活动性肺结核的免疫生物标志物鉴定。
Sci Rep. 2023 Jul 17;13(1):11481. doi: 10.1038/s41598-023-38372-7.
10
Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity.耐多药结核病患者细胞因子飙升,表明存在过度炎症和疾病严重程度。
Sci Rep. 2023 Jan 16;13(1):785. doi: 10.1038/s41598-023-27895-8.
结核病免疫学
Indian J Med Res. 2004 Oct;120(4):213-32.
4
Change in serum concentrations of interleukin-2 and interferon-gamma during treatment of tuberculosis.肺结核治疗期间血清白细胞介素-2和干扰素-γ浓度的变化
J Int Med Res. 2004 May-Jun;32(3):324-30. doi: 10.1177/147323000403200313.
5
Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.白细胞介素-10和转化生长因子β(TGF-β)对肺部免疫反应的下调作用以及活动性肺结核中TGF-β受体I和II的分析
Infect Immun. 2004 May;72(5):2628-34. doi: 10.1128/IAI.72.5.2628-2634.2004.
6
Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations.肺结核患者单核细胞细胞因子分泌情况与健康感染个体不同,且与临床表现相关。
Microbes Infect. 2004 Jan;6(1):25-33. doi: 10.1016/j.micinf.2003.10.007.
7
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis.活动性肺结核患者血浆及支气管肺泡灌洗液中γ干扰素及其调节性细胞因子的评估
Int J Tuberc Lung Dis. 2003 Oct;7(10):994-1000.
8
Human immunity to M. tuberculosis: T cell subsets and antigen processing.人类对结核分枝杆菌的免疫力:T细胞亚群与抗原加工
Tuberculosis (Edinb). 2003;83(1-3):98-106. doi: 10.1016/s1472-9792(02)00054-9.
9
Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.活动性肺结核患者血清肿瘤坏死因子-α、白细胞介素-4及可溶性白细胞介素-2受体水平与影像学及临床表现的相关性
Mediators Inflamm. 2003 Feb;12(1):9-14. doi: 10.1080/0962935031000096926.
10
Depressed interleukin-12 production by peripheral blood mononuclear cells after in vitro stimulation with the 30-kDa antigen in recurrent pulmonary tuberculosis patients.复发性肺结核患者外周血单个核细胞经30-kDa抗原体外刺激后白细胞介素-12分泌减少
Med Microbiol Immunol. 2003 May;192(2):61-9. doi: 10.1007/s00430-002-0117-2. Epub 2002 Oct 31.